BFC Planning, Inc.’s VanEck Biotech ETF BBH Stock Holding History

BFC Planning, Inc.’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.6K	Buy	+47	New	+$8.84K	﹤0.01%	2387

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Miller Investment Management West Conshohocken, Pennsylvania $1.13B AUM 13.3% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Conservest Capital Advisors Wynnewood, Pennsylvania $1.28B AUM 17.34% 1-Year Est. Return

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BFC Planning, Inc.'s BBH Position: Q2 2026 in Review

BFC Planning, Inc. opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 47 shares worth $9.6K. The stake represents ﹤0.01% of the portfolio and ranks #2387 among its holdings.

112 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

BFC Planning, Inc. held 47 shares of VanEck Biotech ETF worth $9.6K as of Q2 2026.
VanEck Biotech ETF was a new BFC Planning, Inc. position in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2387 holding.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.